Mathew Maurer is a Cardiology physician affiliated with Columbia University. OpenAlex indexes 14 publications with 383 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
622 W 168th St
New York, NY 100323720
Telephone
212-305-9808Provider last certified this registry record 23 Apr 2020.
Clinical trials
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Sponsor: Columbia University
- Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Sponsor: Columbia University
- SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
Sponsor: Columbia University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20256 payments$12,950openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year20257 payments
- AstraZeneca UK LimitedProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
8 NIH research awards on record, funded 2001–2026 per NIH RePORTER. The latest:
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Columbia University Health Sciences
FY2026$688,635R01AG081582 - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Columbia University Health Sciences
FY2025$677,958R01AG081582 - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Columbia University Health Sciences
FY2024$685,665R01AG081582
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Deep learning to detect left ventricular structural abnormalities in chest X-rays
European Heart Journal
2024 - Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
The Lancet Diabetes & Endocrinology
2023 - Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
The Lancet Diabetes & Endocrinology
2023 - Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure
American Journal of Kidney Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Serge Przedborski, MD, PhD
Columbia University
Shonni Silverberg, MD
Columbia University
Mitchell Benson, MD
Columbia University
Andrew Lassman, MD
Columbia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”